Not applicableStudy completedNCT02168114What this trial is testingMagnetic Resonance and Optical Imaging of Dystrophic and Damaged MuscleWho this might be right forDuchenne Muscular Dystrophy University of Florida 17
Not applicableLooking for participantsNCT07312214What this trial is testingLED Red Light in Modulating Choroidal Microcirculation to Retard Retinal Atrophy in Pathological MyopiaWho this might be right forPathologic Myopia Shanghai Eye Disease Prevention and Treatment Center 158
Not applicableLooking for participantsNCT04847635What this trial is testingSubthreshold Laser Treatment for Reticular Pseudodrusen Secondary to Age-related Macular DegenerationWho this might be right forMacular Degeneration, SenileLaser Burn of RetinaMacular Degeneration Intermediate+1 more Ospedale San Raffaele 50
Testing effectiveness (Phase 2)Looking for participantsNCT06659549What this trial is testingEfficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMDWho this might be right forGeographic Atrophy of the Macula Galimedix Therapeutics Inc 110
Testing effectiveness (Phase 2)Study completedNCT01445548What this trial is testingSirolimus for Advanced Age-Related Macular DegenerationWho this might be right forAge-Related Macular DegenerationGeographic Atrophy National Eye Institute (NEI) 6
Not applicableStudy completedNCT01692938What this trial is testingEvaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLOWho this might be right forAge-Related Macular DegenerationGeographic AtrophyDiabetic Retinopathy+6 more Optos, PLC 32
Post-approval studies (Phase 4)Study completedNCT04679935What this trial is testingEfficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular DegenerationWho this might be right forAge-related Macular Degeneration Novartis Pharmaceuticals 52
Not applicableLooking for participantsNCT02435940What this trial is testingInherited Retinal Degenerative Disease RegistryWho this might be right forEye Diseases HereditaryRetinal DiseaseAchromatopsia+25 more Foundation Fighting Blindness 20,000
Large-scale testing (Phase 3)Study completedNCT02652767What this trial is testingEfficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 MutationWho this might be right forOptic, Atrophy, Hereditary, Leber GenSight Biologics 39
Not applicableLooking for participantsNCT07392411What this trial is testingStudy on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital BiomarkersWho this might be right forParkinson's DiseaseProgressive Supranuclear Palsy(PSP)Multiple System Atrophy+1 more Beijing Tiantan Hospital 720
Not applicableEnded earlyNCT00599846What this trial is testingThe Natural History of Geographic Atrophy Progression (GAP) StudyWho this might be right forAge-Related Macular DegenerationGeographic Atrophy Alcon Research 1,000
Post-approval studies (Phase 4)Study completedNCT05269966What this trial is testingStudy to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)Who this might be right forNeovascular Age-related Macular Degeneration (nAMD) Novartis Pharmaceuticals 105
Early research (Phase 1)Study completedNCT04014777What this trial is testingStudy of NGM621 in Participants With Geographic AtrophyWho this might be right forGeographic Atrophy NGM Biopharmaceuticals, Inc 15
Large-scale testing (Phase 3)Ended earlyNCT02878694What this trial is testingTreatment of Ptosis to Muscular Dystrophy Oculopharyngeal by Myoblast Autologous GraftWho this might be right forMuscular Dystrophy, OculopharyngealPtosis University Hospital, Caen 1
Early research (Phase 1)Study completedNCT04246866What this trial is testingFirst in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular DegenerationWho this might be right forDry Age-related Macular DegenerationGeographic AtrophyMacular Degeneration+2 more Gemini Therapeutics, Inc. 12
Not applicableLooking for participantsNCT00874783What this trial is testingDevelopment of IPS from Donated Somatic Cells of Patients with Neurological DiseasesWho this might be right forNeurodegenerative Disorders Hadassah Medical Organization 120
Not applicableStudy completedNCT03295071What this trial is testingREALITY LHON RegistryWho this might be right forLeber Hereditary Optic Neuropathy GenSight Biologics 44
Not applicableLooking for participantsNCT06375239What this trial is testingObservational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal DegenerationWho this might be right forRetinitis PigmentosaChoroideremiaStargardt Macular Dystrophy+4 more Ray Therapeutics, Inc. 120
Testing effectiveness (Phase 2)Looking for participantsNCT07158775What this trial is testingEvaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMDWho this might be right forGeographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (AMD) Bionic Sight LLC 40
Not applicableLooking for participantsNCT03988764What this trial is testingMonogenic Diabetes Misdiagnosed as Type 1Who this might be right forDiabetes Mellitus, Type 1Monogenic DiabetesNeonatal Diabetes+4 more McGill University Health Centre/Research Institute of the McGill University Health Centre 5,000